Skip to main content
. Author manuscript; available in PMC: 2005 Dec 6.
Published in final edited form as: N Engl J Med. 2004 Jun 10;350(24):2441–2451. doi: 10.1056/NEJMoa032196

Fig. 1.

Fig. 1

Trial profile. Due to the factorial design, patients were simultaneously randomized to several interventions. One center each was unable to randomize for nitrogen (n=424), remifentanil (191), or both (181). A total of 4123 patients were thus factorially randomized to all six primary factors with 4086 providing analyzable data.

HHS Vulnerability Disclosure